Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 7 | 54 | -0,20 % | ||
| AVADEL PHARMACEUTICALS | 7 | 6 | 0,00 % | ||
| BIONTECH | 6 | 13 | -0,06 % | ||
| DENALI THERAPEUTICS | 5 | - | +0,43 % | ||
| KYMERA THERAPEUTICS | 4 | 6 | +3,46 % | ||
| TERNS PHARMACEUTICALS | 4 | 2 | +2,62 % | ||
| DYNE THERAPEUTICS | 4 | - | +6,72 % | ||
| LEXICON PHARMACEUTICALS | 3 | 4 | +3,18 % | ||
| NURIX THERAPEUTICS | 3 | 4 | 0,00 % | ||
| LIGAND PHARMACEUTICALS | 3 | 2 | +1,90 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:18 | Cathie Wood's ARK sells Iridium stock, buys Nurix on Wednesday | 2 | Investing.com | ||
| 00:31 | Why Dyne Therapeutics Stock Was a Big Winner on Wednesday | 1 | The Motley Fool | ||
| 00:06 | Fortrea Holdings Inc: Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Mi | 59 NORTH COMMUNICATIONS: Nanexa and Moderna enter into license and option agreement for the development of PharmaShell-based products | 3 | Cision News | ||
| Mi | Crinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Mi | Vera Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | Rhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase 2 Trial Evaluating Setmelanotide in Prader-Willi Syndrome | 2 | GlobeNewswire (USA) | ||
| Mi | BIONTECH SE ADR steht still - für mich das lauteste Signal! | 24 | Maximilian Berger | ||
| Mi | Mirum Pharmaceuticals: Leerink hebt Kursziel auf 100 US-Dollar an | 2 | Investing.com Deutsch | ||
| Mi | Mirum Pharmaceuticals stock price target raised to $100 by Leerink | 3 | Investing.com | ||
| Mi | Jefferies raises Olema Pharmaceuticals stock price target to $43 on SERD validation | 8 | Investing.com | ||
| Mi | Omeros Corporation (OMER): Novo Nordisk Deal Creating Buzz | 107 | Insider Monkey | ||
| Mi | Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage | 1 | Insider Monkey | ||
| Mi | Ascendis Pharma A/S - 6-K, Report of foreign issuer | - | SEC Filings | ||
| Mi | GALAPAGOS NV - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| Mi | AstraZeneca-, Gilead-backed program reduced side effects, distress in Black breast cancer patients: study | 4 | FiercePharma | ||
| Mi | RIGEL PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings | ||
| Mi | 4D Molecular Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | Nuvalent, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Mi | Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity | 1 | Seeking Alpha |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .